Clinical trials
Not yet recruiting Metabolic Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ali Aminian | 1 |
| Cambridge Health Alliance | 1 |
| Gary Van Guilder | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Stanford University | 1 |
| Texas Tech University Health Sciences Center | 1 |
| University of Massachusetts, Worcester | 1 |
| University of Wisconsin, Madison | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 9 |
| Diabetes Mellitus | 2 |
| Obesity | 2 |
| Atrial Fibrillation | 1 |
| Bipolar Disorder | 1 |
| Bipolar and Related Disorders | 1 |
| Diabetes, Gestational | 1 |
| Hyperemia | 1 |
| Insulin Resistance | 1 |
| Ketosis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.